4
Changes in Ownership
Vericel Corp Filed Acc 0001179110-12-010819
Options or other derivatives
- VP Clinical Development acquired 151,937 shares (grant or award)
- VP Clinical Development returned 151,937 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Watling Sharon VP Clinical Development | 2012-06-25 | Returned to the company · Stock Option (right to buy) | +151,937 | $2.26 | $343,378 | 69,063 | D |
| Watling Sharon VP Clinical Development | 2012-06-25 | Grant or award · Stock Option (right to buy) | +151,937 | $2.26 | $343,378 | 151,937 | D |
Loading xslF345X03/edgar.xml…